Related Experiment Videos
Structure, binding, and antagonists in the IL-4/IL-13 receptor system
Thomas D Mueller1, Jin-Li Zhang, Walter Sebald
1Physiological Chemistry II, Biocenter, University of Wuerzburg, Am Hubland, Germany.
Biochimica Et Biophysica Acta
|November 8, 2002
Summary
Interleukin-4 (IL-4) and IL-13 receptor antagonists block allergic responses by inhibiting cytokine binding. These IL-4 antagonists show promise in treating allergic diseases and asthma.
Area of Science:
- Immunology
- Molecular Biology
- Allergy Research
Background:
- Interleukin-4 (IL-4) and IL-13 share the IL-4 receptor alpha (IL-4Ralpha) chain, mediating overlapping functions.
- These cytokines are critical in allergic hypersensitivity and exacerbating asthma symptoms.
Purpose of the Study:
- To investigate the structural and functional basis of IL-4 and IL-13 interactions with IL-4Ralpha.
- To develop IL-4 antagonists for blocking detrimental allergic responses.
Main Methods:
- Mutational analysis of IL-4 to create high-affinity IL-4Ralpha binders.
- Structure analysis of the IL-4/IL-4Ralpha complex.
- In vitro and in vivo studies of IL-4 antagonist efficacy.
Main Results:
- Identified IL-4 variants (antagonists) binding IL-4Ralpha but not other receptor subunits.
- Demonstrated that IL-4 antagonists block IL-4 and IL-13 signaling in vitro.
- Showed IL-4 antagonists prevent allergic disease development in vivo.
Conclusions:
- IL-4 antagonists effectively block IL-4 and IL-13 mediated allergic responses.
- An IL-4 antagonist is in clinical trials for asthma treatment.
- Structural insights pave the way for designing small molecule mimetics.